Rheumatoid Arthritis Clinical Trials in Chicago

Showing 821-840 of 3,890 trials

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

NCT06049680

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of parenteral nutrition treatment with SMOFlipid.

Malnutrition, ChildMalnutritionEssential Fatty Acid Deficiency (EFAD)+1 more

Fresenius Kabi100 participantsStarted Oct 2024

Atlanta, Georgia, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +2 more locations

TERMINATEDPhase 22.2 miles

A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis

NCT05516758

The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoid arthritis.

Rheumatoid ArthritisArthritisJoint Diseases+5 more

Eli Lilly and Company491 participantsStarted Aug 2022

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Glendale, Arizona, United States +128 more locations

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Rheumatoid Arthritis Trials in Other Cities

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Stellate Ganglion Block for PTSD

Ranibizumab and Reduced Fluence PDT for AMD

Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

Agili-C™ Implant Performance Evaluation

A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation

Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2

Tube Size Randomized Trial During Emergency Tracheal Intubation

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

PAS-004 in Patients With Advanced Solid Tumors

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Other Conditions in Chicago